[HTML][HTML] PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation

T Varga, Z Czimmerer, L Nagy - … et Biophysica Acta (BBA)-Molecular Basis …, 2011 - Elsevier
Cells are constantly exposed to a large variety of lipids. Traditionally, these molecules were
thought to serve as simple energy storing molecules. More recently it has been realized that …

[HTML][HTML] Regulation of Nox enzymes expression in vascular pathophysiology: focusing on transcription factors and epigenetic mechanisms

SA Manea, A Constantin, G Manda, S Sasson… - Redox biology, 2015 - Elsevier
NADPH oxidases (Nox) represent a family of hetero-oligomeric enzymes whose exclusive
biological function is the generation of reactive oxygen species (ROS). Nox-derived ROS are …

Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease

E Robinson, DJ Grieve - Pharmacology & therapeutics, 2009 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear
transcription factors that belong to the nuclear receptor superfamily. Three isoforms of PPAR …

Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites

TD O'Connell, RP Mason, MJ Budoff… - European Heart …, 2020 - academic.oup.com
Patients with well-controlled low-density lipoprotein cholesterol levels, but persistent high
triglycerides, remain at increased risk for cardiovascular events as evidenced by multiple …

Peroxisome proliferator-activated receptor α in lipid metabolism and atherosclerosis

XH Yu, XL Zheng, CK Tang - Advances in clinical chemistry, 2015 - Elsevier
Atherosclerosis is a chronic inflammatory disease with deposition of excessive cholesterol in
the arterial intima. Peroxisome proliferator-activated receptor α (PPARα) is a nuclear …

Peroxisome proliferator–activated receptor-α gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice

F Lalloyer, K Wouters, M Baron, S Caron… - … , and vascular biology, 2011 - Am Heart Assoc
Objective—Peroxisome proliferator–activated receptor-α (PPARα) is a ligand-activated
transcription factor that controls lipid metabolism and inflammation. PPARα is activated by …

Hemodynamic Effects of Fenofibrate and Coenzyme Q10 in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction

GT Chew, GF Watts, TME Davis, BGA Stuckey… - Diabetes …, 2008 - Am Diabetes Assoc
OBJECTIVE—To investigate the effects of fenofibrate and coenzyme Q10 (CoQ) on diastolic
function, ambulatory blood pressure (ABP), and heart rate (HR) in type 2 diabetic subjects …

PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1

W Wang, Q Fang, Z Zhang, D Wang, L Wu… - Frontiers in …, 2020 - frontiersin.org
Doxorubicin (DOX), a chemotherapeutic drug widely used in the clinical setting, is known to
cause serious cardiotoxicity and greatly reduces the survival rate as well as quality of life of …

The peroxisome proliferator‐activated receptors in cardiovascular diseases: experimental benefits and clinical challenges

WS Cheang, XY Tian, WT Wong… - British journal of …, 2015 - Wiley Online Library
The peroxisome proliferator‐activated receptors, PPAR α, PPAR β/δ and PPAR γ, are ligand‐
activated transcriptional factors belonging to the nuclear receptors superfamily and they are …

PPARs in the renal regulation of systemic blood pressure

T Rőszer, M Ricote - Ppar Research, 2010 - Wiley Online Library
Recent research has revealed roles for the peroxisome proliferator activated receptor
(PPAR) family of transcription factors in blood pressure regulation, expanding the possible …